PHARVARIS NV share price logo

PHARVARIS NV Share Price

NASDAQ: PHVS

Small Cap

$25.22

-0.48

(-1.87%)

as on

PHARVARIS NV Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $24.95
    $25.70
    downward going graph

    1.07%

    Downside

    1.90%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $11.51
    $29.80
    downward going graph

    54.36%

    Downside

    18.15%

    Upside

    downward going graph

PHARVARIS NV share price movements today

Previous Close
$25.70
Open
$25.70
Volume
218.6K
Day's Low - High
$24.95 - $25.70
52 Week Low - High
$11.51 - $29.80

PHARVARIS NV Historical Returns

1 Month Return
-6 %
3 Month Return
+ 0.58 %
1 Year Return
+ 68.83 %
3 Year Return
+ 284.05 %
5 Year Return
-19.73 %

PHARVARIS NV Stock Fundamentals & Key Indicators

Check PHARVARIS NV market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-2.7653

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-167.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-53.76%

PHARVARIS NV vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PHARVARIS NV with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
PHARVARIS NV image
PHARVARIS NV
BUY$1.7B-19.73%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B125.13%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.56%29.6732.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B56.01%17.6731.41%

Stock Returns calculator for PHARVARIS NV Stock including INR - Dollar returns

The PHARVARIS NV stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

PHARVARIS NV investment value today

Current value as on today

₹1,73,307

Returns

₹73,307

(+73.31%)

Returns from PHARVARIS NV Stock

₹63,766 (+63.77%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on PHARVARIS NV Stock

Based on 13 analysts

BUY

84.62%

Buy

7.69%

Hold

7.69%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for PHARVARIS NV. Average target price of $46.16

PHARVARIS NV Share Price Target

Get share price movements and forecasts by analysts on PHARVARIS NV.

What analysts predicted

45.36%UPSIDE

Target Price

$46.16

Current Price

$25.22

Analyzed by

13 Analysts

Target

$46.16

PHARVARIS NV target price $46.16, a slight upside of 45.36% compared to current price of $25.22. According to 13 analysts rating.

PHARVARIS NV Stock’s Investor Sentiment and Interest

Search interest for PHARVARIS NV Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-21% versus previous 30 day period

PHARVARIS NV Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
0
0
-
-
0
-
-
Operating Income
-24
-26
-27
-28
-34
-37
-45
42
-40
-39
EBITDA
-23
-26
-
-28
-34
-37
-
-42
-40
-37
Interest Expense
0
0
-
0
2
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-23
-23
-31
-27
-29
-41
-33
-46
-45
-37
Income Tax Expense
0
0
-
0
0
0
-
0
0
0
Net Income
-25
-25
-35
-30
-31
-46
-36
-50
-45
-37
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PHARVARIS NV Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
-
Operating Income
-4
-8
-28
-54
-86
-96
-145
EBITDA
-4
-8
-29
-54
-86
-96
-145
Interest Expense
-
0
0
0
0
0
-
Depreciation
-
0
0
0
0
0
0
Income Before Tax
-4
-8
-29
-42
-75
-99
-132
Income Tax Expense
0
0
0
0
0
1
1
Net Income
-4
-9
-36
-48
-80
-110
-140
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PHARVARIS NV Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-23
-32
-27
-29
-41
-34
-46
-45
-37
Operating Cash Flow
-23
-23
-24
-27
-33
-34
-38
-29
-30
Investing Cash Flow
0
-
0
0
0
-
0
0
0
Financing Cash Flow
0
261
0
0
0
0
0
0
160
Change in Cash
-20
237
-22
-24
-38
-34
-44
-36
129

PHARVARIS NV Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-8
-26
-42
-75
-99
-132
Operating Cash Flow
-6
-21
-44
-67
-93
-120
Investing Cash Flow
0
0
0
0
0
0
Financing Cash Flow
21
101
143
8
325
2
Change in Cash
14
78
110
-47
229
-110

Insights on PHARVARIS NV

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, PHVS stock has moved up by 243.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PHVS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PHVS has outperformed top 5 stocks with highest market-cap in its industry

About PHARVARIS NV

pharvaris is a preclinical stage company focused on bringing an oral bradykinin b2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (hae) and other b2 receptor-mediated indications. the company reunites the core team responsible for the discovery and approval of the hae treatment icatibant. with novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.
OrganisationPHARVARIS NV
HeadquartersGrafenauweg 8, Zug, Switzerland, 6300
IndustryServices
CEOMr. Berndt Axel Edvard Modig CPA, M.B.A.
E-voting on sharesClick here to vote

Key Management of PHARVARIS NV

Name

Title

Ms. Annick Deschoolmeester

Chief Human Resources Officer

Dr. Peng Lu M.D., Ph.D.

Chief Medical Officer

Maryann Cimino

Director of Corporate Relations

Mr. Berndt Axel Edvard Modig CPA, M.B.A.

Co-Founder, CEO & Executive Director

Mr. David W. Nassif J.D.

CFO, Chief Legal Officer & Corporate Secretary

Ms. Anna Nijdam M.Sc., R.A.

Head of Strategic Finance & Principal Accounting Officer

Dr. Stefan Abele Ph.D.

Chief Technology Operations Officer

Dr. Anne A. Lesage Ph.D.

Chief Early Development Officer

Mr. Wim Souverijns Ph.D.

Chief Commercial Officer

FAQs

What is PHARVARIS NV share price today?

PHARVARIS NV share price today is $25.22 as on at the close of the market. PHARVARIS NV share today touched a day high of $25.7 and a low of $24.95.

What is the 52 week high and 52 week low for PHARVARIS NV share?

PHARVARIS NV share touched a 52 week high of $29.8 on and a 52 week low of $11.51 on . PHARVARIS NV stock price today i.e. is closed at $25.22,which is 15.36% down from its 52 week high and 119.11% up from its 52 week low.

What is PHARVARIS NV's market capitalisation today?

PHARVARIS NV market capitalisation is $0.00T as on .

How to invest in PHARVARIS NV Stock (PHVS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PHARVARIS NV on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PHARVARIS NV Shares that will get you 0.0595 shares as per PHARVARIS NV share price of $25.22 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy PHARVARIS NV Stock (PHVS) from India?

Indian investors can start investing in PHARVARIS NV (PHVS) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in PHARVARIS NV stock (as per the Rupee-Dollar exchange rate as on ). Based on PHARVARIS NV share’s latest price of $25.22 as on March 25, 2026 at 1:29 am IST, you will get 0.3965 shares of PHARVARIS NV. Learn more about fractional shares .

What are the returns that PHARVARIS NV has given to Indian investors in the last 5 years?

PHARVARIS NV stock has given -19.73% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?